Evidence map›Paper›PMID 24386261›Full record

ArticlePloS one2013

Knockdown of Hsc70-5/mortalin induces loss of synaptic mitochondria in a Drosophila Parkinson's disease model.

Jun-Yi Zhu, Natalia Vereshchagina, Vrinda Sreekumar, Lena F Burbulla, Ana C Costa, Katharina J Daub, Dirk Woitalla, L Miguel Martins, Rejko Krüger, Tobias M Rasse

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Mitochondrial chaperones in human health and disease.Free radical biology & medicine · 2022
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Vps54 regulatesBiology open · 2020
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Jun-Yi ZhuJunior Research Group Synaptic Plasticity, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany ; Graduate School of Cellular & Molecular Neuroscience, University of Tübingen, Tübingen, Germany.
Natalia VereshchaginaJunior Research Group Synaptic Plasticity, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Vrinda SreekumarJunior Research Group Synaptic Plasticity, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany ; Graduate School of Cellular & Molecular Neuroscience, University of Tübingen, Tübingen, Germany ; German Center for Neurodegenerative Diseases, Tübingen, Germany.
Lena F BurbullaGerman Center for Neurodegenerative Diseases, Tübingen, Germany ; Department of Neurodegenerative Diseases and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Ana C CostaCell Death Regulation Laboratory, MRC Toxicology Unit, Leicester, United Kingdom.
Katharina J DaubJunior Research Group Synaptic Plasticity, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Dirk WoitallaDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
L Miguel MartinsCell Death Regulation Laboratory, MRC Toxicology Unit, Leicester, United Kingdom.
Rejko KrügerGerman Center for Neurodegenerative Diseases, Tübingen, Germany ; Department of Neurodegenerative Diseases and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany ; Werner Reichardt Centre for Integrative Neuroscience, University of Tübingen, Tübingen, Germany.
Tobias M RasseJunior Research Group Synaptic Plasticity, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Hertie Institute for Clinical Brain Research · DEUniversity of Tübingen · DEMRC Toxicology Unit · GBGerman Center for Neurodegenerative Diseases · DERuhr University Bochum · DE

Funding

Medical Research Council MC_U132674518
6 · The paper itself

Abstract

Mortalin is an essential component of the molecular machinery that imports nuclear-encoded proteins into mitochondria, assists in their folding, and protects against damage upon accumulation of dysfunctional, unfolded proteins in aging mitochondria. Mortalin dysfunction associated with Parkinson's disease (PD) increases the vulnerability of cultured cells to proteolytic stress and leads to changes in mitochondrial function and morphology. To date, Drosophila melanogaster has been successfully used to investigate pathogenesis following the loss of several other PD-associated genes. We generated the first loss-of-Hsc70-5/mortalin-function Drosophila model. The reduction of Mortalin expression recapitulates some of the defects observed in the existing Drosophila PD-models, which include reduced ATP levels, abnormal wing posture, shortened life span, and reduced spontaneous locomotor and climbing ability. Dopaminergic neurons seem to be more sensitive to the loss of mortalin than other neuronal sub-types and non-neuronal tissues. The loss of synaptic mitochondria is an early pathological change that might cause later degenerative events. It precedes both behavioral abnormalities and structural changes at the neuromuscular junction (NMJ) of mortalin-knockdown larvae that exhibit increased mitochondrial fragmentation. Autophagy is concomitantly up-regulated, suggesting that mitochondria are degraded via mitophagy. Ex vivo data from human fibroblasts identifies increased mitophagy as an early pathological change that precedes apoptosis. Given the specificity of the observed defects, we are confident that the loss-of-mortalin model presented in this study will be useful for further dissection of the complex network of pathways that underlie the development of mitochondrial parkinsonism.

Indexed as

Gene SilencingAnimalsAutophagyCell SurvivalDisease Models, AnimalDopaminergic NeuronsDrosophilaFemaleGene Knockdown TechniquesGenes, EssentialHSP70 Heat-Shock ProteinsHumansMitochondriaNeuronsParkinson DiseasePhenotypeHSP70 Heat-Shock Proteinsmortalin

Identifiers

PMID24386261
PMCPMC3875477
OpenAlexW2098972637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.